the circle. forum · BILS 2027

Confirm yourattendance.

For invited delegates and confirmed guests.

No code? Contact Herbert Ryan

BILS
request access

the circle. forum · BILS 2027 · Berlin

Your place
is held.

10–11 February 2027.

Hotel Palace Berlin.

By invitation. By relevance. By room.

Curated meetings · BILS 2027

01

You complete the form below. Three questions. Your challenges. Your priorities.

02

GBX Circle matches your profile to the organisations and leaders best placed to respond.

03

We confirm your curated meeting schedule before the forum. You arrive prepared.

Participating partners — Asahi Kasei Bioprocess · Hotel Palace Berlin · 10–11 February 2027

BILS 2027 · Attend

Confirm your attendance.

The senior leaders shaping the next generation of biologics are in this room.

Date

10–11 February 2027

Venue

Hotel Palace Berlin · Berlin

Format

Up to 150 leaders · 80/20 end-user · closed-door

Access

By invitation. By relevance. By room.

Contact · Life Sciences

Herbert Ryan

Manager · Life Sciences · BILS

herbert@gbxcircle.com +44 204 572 7288

For the room

Three questions. Shapes who you sit with and what we prepare.

Current challenges

Select up to two

Process development and scale-up
Viral safety and biosafety
CMC and regulatory strategy
Single-use technology adoption
Manufacturing cost reduction
Other

Current investment areas

Select up to two

Downstream processing
Viral filtration and safety
Manufacturing automation
CDMO partnerships
Facility and capacity
Other

Select up to two

Digital twin · process simulation AI-driven process optimisation Process analytical technology (PAT) Electronic batch records · QMS Manufacturing execution systems (MES) Predictive maintenance None currently active

Select one

CMO and CDMO qualification Raw material traceability and supply security Cold chain integrity and monitoring EMA Annex 1 and EU GMP compliance Digital quality systems · data integrity Risk-based supplier management Container closure integrity

Select one

Active procurement · decision within 6 months Pilot and evaluation stage Horizon planning · 12–24 months Strategic review · no immediate mandate Investment pause · reassessing priorities

Influence means decision authority or material input — not direct control alone

Up to £1M £1M – £10M £10M – £100M £100M – £1B+ Prefer not to disclose

Asahi Kasei Bioprocess · Partner questions

Planova (Asahi Kasei) Viresolve Pro (Merck) Pegasus Prime (Pall) Virosart (Sartorius) Multiple / evaluating Not yet at this stage
Throughput and yield loss Regulatory compliance Scale-up to commercial Filter supply and sourcing Validation complexity Cost per batch

the circle. · BILS 2027